Eloxx Pharmaceuticals, Inc. (ELOX) Cash flow
Market cap
$92.56M
P/E ratio
| 2013/06 | 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2025/12 | |
| Stock-based compensation | 13 | 1 | 480,681 | 156,678 | 80,108 | 0 | 13 | 11 | 9 | 9 | 3 | 0 |
| Cash from operations | -3,902,626 | -4,868,133 | -7,344,696 | -3,676,215 | -1,925,110 | -16 | -31 | -39 | -28 | -35 | -32 | -6 |
| Capital expenditures | -185,947 | -3,194 | -122,641 | - | -2,500 | -0 | -0 | -0 | - | -0 | -0 | - |
| Cash from investing | -529,042 | 646,936 | -259,587 | - | 47,500 | -0 | -0 | -34 | 34 | 2 | -0 | 0 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | 15 | 1 | 12 | - | 3 |
| Cash from financing | 49 | 9 | 5 | 1 | 1 | 38 | 56 | 47 | -3 | 51 | 9 | 11 |
| Free cash flow | - | - |